This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Catamaran Corporation Adds Two New Board Members

Stocks in this article: CTRX

Industry luminaries Betsy Holden and Karen Katen to help guide the firm to its next level of growth

LISLE, Ill, Dec. 11, 2012 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) and technology services, today announced that it appointed Betsy Holden and Karen Katen to Catamaran's Board of Directors, effective December 10, 2012. Ms. Holden and Ms. Katen will round out the firm's board which includes a diverse array of seasoned business leaders representing leading healthcare, IT, private equity, and consumer product companies.

"The appointment of Betsy Holden and Karen Katen - two of the most esteemed women in business today - to Catamaran's board will further enhance our successful shepherding of shareholder interests and our ability to deliver value to clients," said Mark Thierer, Chairman and CEO of Catamaran. "Together, Betsy, with a proven track record of value creation as former CEO of one of the world's most recognized brands, and Karen, a well-respected executive with an impressive healthcare pedigree, bolster Catamaran's commitment to driving smart growth."

Ms. Holden, a Senior Advisor to McKinsey & Company, works with clients across industries on strategy, marketing, innovation and board effectiveness initiatives. Prior to her current position, she was co-CEO of Kraft Foods and CEO of Kraft Foods North America, where she built a strong record of success in brand building, organic growth and cost management for North America's largest food company at the time.

Ms. Katen is a Senior Advisor to Essex Woodlands, a healthcare investment firm, where she focuses on building best-of-breed companies.  Prior to this, Ms. Katen served as Vice Chairman of Pfizer, responsible for providing a broad array of innovative human-health services. With more than 30 years of experience in the healthcare industry, including guiding Pfizer's industry-leading portfolio, Ms. Katen was recognized among Fortune magazine's "50 Most Powerful Women in Business" for eight consecutive years.

About Catamaran Catamaran, the industry's fastest-growing pharmacy benefit manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 250 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit

SOURCE Catamaran

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs